CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$45.15 -4.89 (-9.77%)
At close: Nov 10, 2026 · 4:00 PM EST

CRISPR Therapeutics AG (CRSP) Non Operating Income (2015 - 2026)

Updated

CRISPR Therapeutics AG's Non Operating Income was $18.68 million in Q3 2026, down 28.8% from $26.24 million a year earlier and down 31.0% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) Non Operating Income (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, CRISPR Therapeutics AG's Non Operating Income was $78.68 million through Sep 30, 2026, down 12.4% year-over-year; for FY2025, it came in at $86.61 million, down 16.6% from FY2024.

  • Non Operating Income shows a five-year compound annual growth rate of 68.5% (FY2020 to FY2025).
  • In earlier years, Non Operating Income was $103.9 million in FY2024 (+44.7%), $71.82 million in FY2023 (+216.9%), $22.66 million in FY2022 (+277.5%) and $6 million in FY2021 (-5.9%).
  • Quarterly Non Operating Income has moved between $363,000 (Q1 2022) and $27.98 million (Q4 2024) over five years.
  • Compared with a year earlier, Non Operating Income was higher in three of the last eight quarters, with an average decline of 9.2%.
  • The best year-over-year quarter for Non Operating Income over five years was Q3 2022 (growth of 559.8%); the worst was Q1 2022 (a decline of 81.4%).
  • Per Business Quant data, CRSP's Non Operating Income in the three quarters before Q3 2026 was $27.08 million (Q2 2026), $8.16 million (Q1 2026) and $24.77 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -130.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 CRISPR Therapeutics AG 4.37 Bn -4.68 Bn - 18.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 18.68 Mn
Jun 30, 2026 27.08 Mn
Mar 31, 2026 8.16 Mn
Dec 31, 2025 24.77 Mn
Sep 30, 2025 26.24 Mn
Jun 30, 2025 22.07 Mn
Mar 31, 2025 13.54 Mn
Dec 31, 2024 27.98 Mn
Sep 30, 2024 25.06 Mn
Jun 30, 2024 26.14 Mn
Mar 31, 2024 24.72 Mn
Dec 31, 2023 20.00 Mn
Sep 30, 2023 20.67 Mn
Jun 30, 2023 18.41 Mn
Mar 31, 2023 12.74 Mn
Dec 31, 2022 11.49 Mn
Sep 30, 2022 7.26 Mn
Jun 30, 2022 3.54 Mn
Mar 31, 2022 363,000.00
Dec 31, 2021 2.20 Mn
API Access

CRISPR Therapeutics AG Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=CRSP&period=max&api_key=YOUR_API_KEY